RxDoctor Payments Data

Gorby Leon, MD

Family Medicine · Byron, GANPI 1679911762

Payments from drug & device makers

$925in general payments, 2019–2025

Across 49 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$238
  • Lilly USA, LLC$124
  • AbbVie$100
  • Pfizer$97
  • Sumitomo Pharma America, Inc.$74
  • AstraZeneca$60
  • plus $231 from 9 others

What the payments were for

  • Food & beverage$925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$925 in reported general payments places this provider in the 55th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$52,706
Medicare patients
128
Services billed
778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide244$321,035
EliquisApixaban137$125,315
OzempicSemaglutide91$115,836
LinzessLinaclotide114$82,147
TrulicityDulaglutide56$69,848
RybelsusSemaglutide37$46,218
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$40,748
JanuviaSitagliptin Phosphate26$34,566
FarxigaDapagliflozin Propanediol34$27,469
MyrbetriqMirabegron25$23,895
VraylarCariprazine Hcl12$22,481
XareltoRivaroxaban25$21,864
JardianceEmpagliflozin22$20,566
Breo ElliptaFluticasone/Vilanterol20$17,568
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen610$16,675

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$124$390,883300 claims
Novo NordiskOzempic, Rybelsus$238$162,055128 claims
PfizerEliquis$97$125,315137 claims
AbbVieLinzess, Vraylar, Creon$100$120,143141 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$21$63,45481 claims
AstraZenecaFarxiga, Symbicort$60$33,70551 claims
Johnson & JohnsonXarelto$15$21,86425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Byron

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →